Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 16

Page
per page
  1. PX 12
    A4509 PX 12
    Target: Trx
    Summary: Trx-1 inhibitor
      insoluble in H2O; ≥8.75 mg/mL
  2. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR inhibitor
  3. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    Target: ErbB
    Summary: HER inhibitor
      ≥23.5 mg/mL
  4. Z-IETD-FMK
    B3232 Z-IETD-FMK
     12 Citation
    Target: Caspases
    Summary: Caspase-8 inhibitor
      ≥32.73 mg/mL
  5. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: inhibitor of Ubiquitin-Activating Enzyme (E1)
  6. Pentostatin
    A3708 Pentostatin
     1 Citation
    Target: Adenosine Deaminases
    Summary: Irreversible adenosine deaminase inhibitor
      ≥26.8 mg/mL
  7. AZD-9291
    B1104 AZD-9291
     1 Citation
    Target: EGFR
    Summary: Mutated forms EGFR inhibitor
      ≥24.98 mg/mL
  8. THZ1
    A8882 THZ1
     12 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Covalent CDK7 inhibitor,potent and selective
      ≥28.3 mg/mL
  9. Epoxomicin
    A2606 Epoxomicin
     25 Citation
    Summary: Proteasome inhibitor
      ≥27.73 mg/mL
  10. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO

Items 1-10 of 16

Page
per page